GRNTI 76.35 Прочие отрасли медицины и здравоохранения
In order to identify promising strategic development possibilities for the pharmaceutical industry in the Russian Federation, a pilot study was conducted, which has analyzed the main trends in the development of innovative medicines. As a result of the content analysis of available sources of scientific literature, the characteristics of options used in the world practice for increasing the innovative activity of individual subjects and the pharmaceutical market as a whole are presented. Possible reserves for the further development of the innovative component of the pharmaceutical market within the framework of the concept of personalized medicine according to the P4 principle (predictive - personalized - preventive - participatory) are identified and structured. The results of use by individual pharmaceutical companies of scientifically and practically justified approaches to optimizing the costs of development and promoting drugs are presented. The advantages and real prospects of a generally accepted method to reduce the cost of development by «expanding the pharmacological effect» (label expansion) of already existing drugs with a known safety profile in the world practice are shown. A scientific generalization and structuring of the goals and results of the post-registration phase of clinical trials to expand the pharmacological action of a number of drugs already existed at the market have been carried out.
pharmaceutical development, innovative medicines, clinical trials, postmarketing research, optimization of costs for the medicines development
1. Entwicklungstrends und probleme des russischen Pharma-Markts in 2016 / Glembotzkaja G.T., Kriwoschejew S.A., Jerjomin S. J., Filatowa I.W., Wenzel N. - Pharmind. - 2017. - № 12. - S. 1622-1629.
2. Rogova E.M., Sirik E.S. Ocenka innovacionnyh proektov v farmacevticheskoy otrasli: podhod na osnove integracii real'nyh opcionov i nechetkih mnozhestv. - Menedzhment innovaciy. - 2014. - № 4. - S. 268-278.
3. Shilov G.N., Homenko A.I., Evstigneev V.V. Osnovy razvitiya novyh lekarstvennyh sredstv. - Medicinskie novosti. - 2009. - № 2. - S.23-28.
4. Kravchenko D.V., Korzinov O.M. Est' li buduschee u rossiyskih innovacionnyh lekarstv? - Remedium. - 2008. - № 11. - C. 9-20.
5. Farm-giganty planiruyut ispol'zovat' blokcheyn dlya snizheniya stoimosti razrabotki lekarstv. - COINFOX. - 09.01.2018. Rezhim dostupa: http://www.coinfox.ru/novosti/8557-farm-giganty-planiruyut-ispolzovat-blokchejn-dlya-snizheniya-stoimosti-razrabotki-lekarstv. (Data obrascheniya: 25.01.2019)
6. Sysuev B., Rud'ko A. Superdzheneriki - novyy vektor razvitiya farmacevtiki. - Novosti GMP. - Osen' 2018. - № 3 (17).
7. Glembockaya G.T., Tihonova Yu.A., Krivosheev S.A., Eremin S.Yu., Kutenkova E.L. Rezervy optimizacii deyatel'nosti specialistov po registracii lekarstvennyh sredstv farmacevticheskih kompaniy. - Biofarmacevticheskiy zhurnal. - 2018. - T. 10. - № 5. - S. 20-27.
8. Eremin S.Yu., Glembockaya G.T. Obosnovanie aktual'nosti vybora na blizhayshuyu perspektivu resursosberegayuschey strategii innovacionnoy aktivnosti kompaniyami-proizvoditelyami lekarstvennyh preparatov // Sbornik materialov XXV Rossiyskogo nacional'nogo kongressa «Chelovek i lekarstvo». - Moskva, 9-12 aprelya 2018. - S. 66-67.
9. Voronkov M. Mifologiya innovacionnyh lekarstv. - Moskovskie apteki. - 2007. - № 5. - S. 12-13.
10. FDA odobrilo rasshirenie pokazaniy preparata Avastin (Bevacizumab) / VIDAL. - 05.08.2009. Rezhim dostupa: https://www.vidal.ru/novosti/fda-odobrilo-rasshirenie-pokazanij-preparata-avastin-bevatsizumab-411. (Data obrascheniya: 24.01.2019)
11. CHMP rekomenduet rasshirenie pokazaniy k primeneniyu Glivec / Apteka. - 30 marta 2009. - № 13 (684). Rezhim dostupa: https://www.apteka.ua/article/8239. (Data obrascheniya: 25.01.2019)
12. Nagaraj A.B. Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment / Oncogene. - 2017, Oct 2.
13. Belousov D.Yu. Postregistracionnye klinicheskie issledovaniya. - Kachestvennaya klinicheskaya praktika. - 2017. - № 1. - S. 20-23.
14. Shustova G. Postregistracionnye klinicheskie issledovaniya. - Remedium. - 2005. - № 1-2. - S. 55-58.
15. Glembockaya G.T., Eremin S.Yu., Saidova M.N. Poisk effektivnyh strategiy optimizacii zatrat na razrabotku innovacionnyh lekarstvennyh preparatov // Materialy respublikanskoy konferencii na temu «Aktual'nye problemy sovremennoy mediciny i farmacii: vzglyad v buduschee». - Dushanbe, 13 noyabrya 2018. - S. 102-104.
